Guidance for Organ Donation and Transplantation Professionals Regarding the Zika Virus
Published 4 February 2016
UNOS; Feb 2016.

Zika virus is a flavivirus transmitted by Aedes (Stegomyia) mosquitoes, most commonly by A. aegypti. Zika virus has been recognized in Brazil since 2014, and local transmission now has been reported in more than 20 countries and territories in the Western Hemisphere, including South America, Central America, Mexico, and the Caribbean.
The OPTN/UNOS Ad Hoc Disease Transmission Advisory Committee (DTAC), the American Society of Transplantation (AST), and the American Society of Transplant Surgeons (ASTS), after careful review of information available from the Centers for Disease Control and Prevention (CDC), offers this information to transplant centers and Organ Procurement Organizations (OPOs) in light of recent spread of Zika virus throughout large parts of the Americas.
Read at UNOSRelated Guidlines
-
ISHLT Consensus Statement on Adult and Pediatric Airway Complications after Lung Transplantation
-
Implementation Framework for the ISHLT Statement on Transplant Ethics
-
Donor Heart and Lung Procurement: A Consensus Statement
-
The 2015 ISHLT Guidelines for the Management of Fungal Infections in Mechanical Circulatory Support and Cardiothoracic Organ Transplant Recipients: Executive Summary
-
Test: Impact of Preoperative Temporary Mechanical Circulatory Support on Durable LVAD Outcomes An Analysis of The Society of Thoracic Surgeons National Intermacs Database

